Work

Fatigue: A Long Standing Symptom Affecting Quality of Life in Patients Following Hematopoietic Cell Transplantation

Year: 2013

Type: article

Abstract: Hematopoietic stem cell transplantation (HSCT) is a potentially curative therapy for malignant and autoimmune diseases. As the scope of transplant expands treatment for more diseases and patient types, quality of life (QOL) specifically fatigue, will remain an important measure for outcome and long term survival in HSCT. Overall QOL is reported to return to baseline or exceeds baseline by one year while fatigue remains a major symptom that is long lasting as far out as 10 years.

Source: Transplantation and Cellular Therapy

DOI: 10.1016/j.bbmt.2012.11.247

Authors: Therese Hennig, David Rizzieri, Amy Abernathy, Tanya Helms, Nelson J. Chao

Institutions: Duke Medical Center, Duke University

Language: English

Topic: Cancer survivorship and care

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $3,650